Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors

Luana Guimarães de Sousa(The University of Texas MD Anderson Cancer Center), Renata Ferrarotto(The University of Texas MD Anderson Cancer Center)
Clinical Cancer Research
May 31, 2023
10.1158/1078-0432.ccr-23-0514
Cited by 28

Related Papers

Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in <i> BRAF <sup>V600E</sup> </i> -Mutated Anaplastic Thyroid Carcinoma
|Thyroid|2019|229
Phase 2 study of pembrolizumab in patients with advanced rare cancers
|Journal for ImmunoTherapy of Cancer|2020|130
Initial Management of <i>BRAF </i>V600E-Variant Anaplastic Thyroid Cancer
|JAMA Oncology|2024|35
Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid Cancer
|Thyroid|2025|8
Reimagining the Therapeutic Approach for Anaplastic Thyroid Cancer: The Roadmap to a Cure
|Thyroid|2025|5